Trabeculectomy with Mitomycin C. Outcomes and Risk Factors for Failure in Phakic Open-Angle Glaucoma

Ophthalmology

Volumn 113, Issue 6, 2006, Pages 930-936

  Fontana, Hector ^a   Nouri Mahdavi, Kouros ^a   Lumba, Joanna ^a   Ralli, Monica ^a   Caprioli, Joseph ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; AGE DISTRIBUTION; AGED; ARGON LASER; ARTICLE; CONTROLLED STUDY; FEMALE; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; LASER; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK; RISK FACTOR; SURVIVAL RATE; SUTURE; TRABECULECTOMY; TRABECULOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; INTRAOPERATIVE COMPLICATIONS; LENS, CRYSTALLINE; MALE; MIDDLE AGED; MITOMYCIN; RETROSPECTIVE STUDIES; RISK FACTORS; TRABECULECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33646934345     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.01.062     Document Type: Article

References (46)

1. Lichter P.R., Musch D.C., Gillespie B.W., et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108 (2001) 1943-1953
2. Migdal C., Gregory W., and Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 101 (1994) 1651-1656 discussion 1657
3. Wilensky J.T., Zeimer R.C., Gieser D.K., and Kaplan B.H. The effects of glaucoma filtering surgery on the variability of diurnal intraocular pressure. Trans Am Ophthalmol Soc 92 (1994) 377-381 discussion 381-3
4. Schwartz K., and Budenz D. Current management of glaucoma. Curr Opin Ophthalmol 15 (2004) 119-126
5. Singh K., Mehta K., Shaikh N.M., et al. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology 107 (2000) 2305-2309
6. Heuer D.K., Parrish II R.K., Gressel M.G., et al., A pilot study. 5-Fluorouracil and glaucoma filtering surgery. II. Ophthalmology 91 (1984) 384-394
7. Kitazawa Y., Kawase K., Matsushita H., and Minobe M. Trabeculectomy with mitomycin. a comparative study with fluorouracil. Arch Ophthalmol 109 (1991) 1693-1698
8. Skuta G.L., Beeson C.C., Higginbotham E.J., et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 99 (1992) 438-444
9. Smith M.F., Sherwood M.B., Doyle J.W., and Khaw P.T. Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma. Am J Ophthalmol 114 (1992) 737-741
10. Egbert P.R., Williams A.S., Singh K., et al. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol 116 (1993) 612-616
11. Higginbotham E.J., Stevens R.K., Musch D.C., et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 103 (1996) 650-656
12. Greenfield D.S., and Parrish II R.K. Bleb rupture following filtering surgery with mitomycin-C. pathologic correlations. Ophthalmic Surg Lasers 27 (1996) 876-877
13. Susanna Jr. R., Takahashi W., and Nicolela M. Late bleb leakage after trabeculectomy with 5-fluorouracil or mitomycin C. Can J Ophthalmol 31 (1996) 296-300
14. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study. 7. Results. Am J Ophthalmol 120 (1995) 718-731
15. Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 121 (1996) 349-366
16. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
17. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126 (1998) 487-497
18. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study. a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713 discussion 829-30
19. Nouri-Mahdavi K., Brigatti L., Weitzman M., and Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology 102 (1995) 1760-1769
20. Mora J.S., Nguyen N., Iwach A.G., et al. Trabeculectomy with intraoperative sponge 5-fluorouracil. Ophthalmology 103 (1996) 963-970
21. Kim Y.Y., Sexton R.M., Shin D.H., et al. Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. Am J Ophthalmol 126 (1998) 755-762
22. Kupin T.H., Juzych M.S., Shin D.H., et al. Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am J Ophthalmol 119 (1995) 30-39
23. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
24. Mao L.K., Stewart W.C., and Shields M.B. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 111 (1991) 51-55
25. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology 105 (1998) 1146-1164
26. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 3. Baseline characteristics of black and white patients. Ophthalmology 105 (1998) 1137-1145
27. Bergea B., Bodin L., and Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 106 (1999) 997-1004 discussion 1004-5
28. Scott I.U., Greenfield D.S., Schiffman J., et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol 116 (1998) 286-291
29. Beckers H.J., Kinders K.C., and Webers C.A. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 241 (2003) 106-110
30. Casson R., Rahman R., and Salmon J.F. Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol 85 (2001) 686-688
31. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 134 (2002) 481-498
32. Rebolleda G., and Munoz-Negrete F.J. Effect of cataract surgery on IOP after trabeculectomy [letter]. J Cataract Refract Surg 29 (2003) 2043
33. Hayashi K., Hayashi H., Nakao F., and Hayashi F. Effect of cataract surgery on intraocular pressure control in glaucoma patients. J Cataract Refract Surg 27 (2001) 1779-1786
34. Shingleton B.J., Gamell L.S., O'Donoghue M.W., et al. Long-term changes in intraocular pressure after clear corneal phacoemulsification. normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg 25 (1999) 885-890
35. Kim D.D., Doyle J.W., and Smith M.F. Intraocular pressure reduction following phacoemulsification cataract extraction with posterior chamber lens implantation in glaucoma patients. Ophthalmic Surg Lasers 30 (1999) 37-40
36. Stamper R.L., McMenemy M.G., and Lieberman M.F. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol 114 (1992) 544-553
37. Costa V.P., Wilson R.P., Moster M.R., et al. Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic Surg 24 (1993) 389-394
38. Shields M.B., Scroggs M.W., Sloop C.M., and Simmons R.B. Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthalmol 116 (1993) 673-683
39. Bindlish R., Condon G.P., Schlosser J.D., et al. Efficacy and safety of mitomycin-C in primary trabeculectomy. five-year follow-up. Ophthalmology 109 (2002) 1336-1341 discussion 1341-2
40. Azuara-Blanco A., and Katz L.J. Dysfunctional filtering blebs. Surv Ophthalmol 43 (1998) 93-126
41. Suñer I.J., Greenfield D.S., Miller M.P., et al. Hypotony maculopathy after filtering surgery with mitomycin C. incidence and treatment. Ophthalmology 104 (1997) 207-214 discussion 214-5
42. Singh K., Byrd S., Egbert P.R., and Budenz D. Risk of hypotony after primary trabeculectomy with antifibrotic agents in a black west African population. J Glaucoma 7 (1998) 82-85
43. Poulsen E.J., and Allingham R.R. Characteristics and risk factors of infections after glaucoma filtering surgery. J Glaucoma 9 (2000) 438-443
44. Parrish R., and Minckler D. "Late endophthalmitis"-filtering surgery time bomb?. Ophthalmology 103 (1996) 1167-1168
45. DeBry P.W., Perkins T.W., Heatley G., et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 120 (2002) 297-300
46. Wells A.P., Cordeiro M.F., Bunce C., and Khaw P.T. Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology 110 (2003) 2192-2197